Health Care & Life Sciences » Pharmaceuticals | Biofermin Pharmaceutical Co. Ltd.

Biofermin Pharmaceutical Co. Ltd. | Ownership

Companies that own Biofermin Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Management & Research Co.
114,497
0.94%
99
0%
07/31/2018
Fidelity (Canada) Asset Management ULC
75,000
0.62%
0
0%
07/31/2018
Nomura Asset Management Co., Ltd.
57,499
0.47%
699
0%
07/31/2018
Daiwa Asset Management Co. Ltd.
44,900
0.37%
8,200
0%
07/31/2018
Dimensional Fund Advisors LP
28,600
0.24%
3,200
0%
04/30/2018
Nikko Asset Management Co., Ltd.
25,200
0.21%
0
0%
08/20/2018
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
10,999
0.09%
-101
0%
07/31/2018
AQR Capital Management LLC
3,600
0.03%
800
0%
02/28/2018
Simplex Asset Management Co., Ltd.
3,100
0.03%
200
0.01%
03/21/2017
Asset Management One Co., Ltd.
2,999
0.03%
99
0%
04/20/2018

About Biofermin Pharmaceutical Co.

View Profile
Address
Sannomiya Central Building, 12/F
Kobe Hyogo 650
Japan
Employees -
Website http://www.biofermin.co.jp
Updated 07/08/2019
Biofermin Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceutical products, quasi-drugs, veterinary drugs, agrichemicals, cosmetics, medical equipment, foods, beverages, food additives, feeds, feed additives and other chemicals. Its products include pharmaceutical items such as New Biofermin S, Biofermin Antidiarrheal, Biofermin, Stomachic Tablets, Biofermin VC, Biofermin Laxatives, Biofermin R, etc. It also provides various clinical test services.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.